Showing results (1-10 of 277) with videos related to
Sort By:
Pageof 28
Genes, Chromosomes & Cancer|November 2, 2018
Translating genomic risk into an early detection strategy for sarcomaMandy L Ballinger, Mark Pinese, David M ThomasNature Reviews. Clinical Oncology|April 19, 2019
Author Correction: Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.Nature Reviews. Clinical Oncology|February 21, 2019
Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 15, 2016
Diagnosis and Management of Hereditary SarcomaDavid M Thomas, Mandy L BallingerJournal of Surgical Oncology|October 23, 2014
Etiologic, environmental and inherited risk factors in sarcomasDavid M Thomas, Mandy L BallingerCurrent Opinion in Oncology|June 8, 2015
Surveillance recommendations for patients with germline TP53 mutationsMandy L Ballinger, Gillian Mitchell, David M ThomasThe Lancet. Oncology|June 13, 2015
Clinical implications of genomics for cancer risk geneticsDavid M Thomas, Paul A James, Mandy L BallingerBMC Medical Genetics|May 5, 2019
Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohortsRachel M Jones, Phillip E Melton, Mark Pinese, et al.Asia-Pacific Journal of Clinical Oncology|March 1, 2016
International survey of awareness of genetic risk in the clinical sarcoma communityKate A McBride, Timothy E Schlub, Mandy L Ballinger, et al.Surgery|October 18, 2024
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) programElan Novis, Anthony Glover, John P Grady, et al.Pageof 28